December 28, 2014 7:42 AM ET

Pharmaceuticals

Company Overview of Regenex Corporation Co. Ltd.

Company Overview

Regenex Corporation Co. Ltd. engages in the research, development, and manufacture of pharmaceutical products. The company manufactures birth control drugs, such as oral contraceptives, including levonorgestrel enteric-coated tablet, an emergency contraceptive; and condoms with water-based lubricants. Its products also include anti-neoplastic drugs, which include foreign anti-tumor drugs, such as hydrochloric acid doxorubicin liposomes injections; antibiotic agents that consist of Amphotericin B Liposome for injection; and geriatric drugs. The company is based in Guangzhou, China.

Guangzhou Science City

Jinfeng Road 3

Guangzhou,  510530

China

Phone:

86 20 3208 6229

Fax:

86 20 3208 6227

Key Executives for Regenex Corporation Co. Ltd.

Regenex Corporation Co. Ltd. does not have any Key Executives recorded.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Regenex Corporation Co. Ltd., please visit www.regenex.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.